Our start-up portfolio
We've built an incredible production line for start-up companies to bring early-stage technologies out of the research lab and translate them into patient benefit. Our start-up portfolio secures funding from investors around the world who believe in our world class science and the power of partnership.

79
start-ups formed across therapeutics, diagnostics and medtech
23
start-up exits to date
£3bn
raised by our start-up portfolio
Active start-ups

52North
Seed | Medtech

Achilles Therapeutics
Therapeutics

ADC Therapeutics
Therapeutics

Adendra Therapeutics
Seed | Therapeutics

Akamis Bio
Therapeutics

Alethiomics
Therapeutics

Amplia Therapeutics
Therapeutics

Artios
Collaboration | Therapeutics

Biocaptiva
Seed | Medtech

BliNK Biomedical
Therapeutics

Cyted
Diagnostics

Elaitra
Seed | Data and AI | Medtech

Enedra
Pre-seed | Therapeutics

Incanthera
Therapeutics

Infinitopes
Seed | Therapeutics

iOnctura
Collaboration | Therapeutics

Mantra diagnostics
Diagnostics

Mission Therapeutics
Therapeutics

Myricx Bio
Series A | Therapeutics

Neobe Therapeutics
Seed | Therapeutics

NK:IO
Seed | Therapeutics

OligoTune
Collaboration | Pre-seed | Therapeutics

Oxomics
Diagnostics

Papivax
Therapeutics

Revitope Oncology
Therapeutics

Sentinal4D
Data | AI

Singula Bio
Therapeutics

Spliceor
Therapeutics

Storm Therapeutics
Therapeutics

Stratosvir
Pre-seed | Therapeutics

Stroma Biosciences
Therapeutics

Suil Vision
Seed | Data and AI

Trogenix
Seed | Therapeutics

Verinnogen
Early-stage capital | Therapeutics
Exited start-ups

Abcodia

Adaptate Biotherapeutics

Autolus

Curis

Cyclacel

Epistem

GammaDelta Therapeutics

Genextra

Infermed

Inivata

KuDOS Pharmaceuticals

Monte Rosa Therapeutics

The Native Antigen Company

Photo Therapeutics

Piramed

Sorrento Therapeutics

Spirogen
Let's go further, faster, together
Find out how to invest in one of our portfolio companies or get support to start your own.